Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey
- PMID: 37195550
- DOI: 10.1007/s12026-023-09389-x
Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey
Abstract
Antinuclear antibodies (ANA) are the most widely used immunological test for the diagnosis of autoimmune diseases. Despite the recommendations of experts, there is some variability in performing and interpreting this test in routine practice. In this context, the Spanish Group on Autoimmune Diseases (GEAI) of the Spanish Society of Immunology (SEI) conducted a national survey of 50 autoimmunity laboratories. Here we report the survey results on ANA testing, detection of related antigens, and our recommendations. The survey showed that most of the participating laboratories use a similar approach for most key practices: 84% perform ANA by indirect immunofluorescence (IIF) on HEp-2 cells as the screening methodology while the other laboratories use IIF to confirm positive screens; 90% report ANA test results as either negative or positive with titer and pattern; 86% indicated that the ANA pattern conditioned follow-up testing for specific antigen-related antibodies; and 70% confirm positive anti-dsDNA. However, testing practices were highly heterogeneous for certain items, such as sera dilutions and the minimum time period for repeating ANA and related antigen determinations. Overall, this survey shows that most autoimmune laboratories in Spain use a similar approach but that further standardization of testing and reporting protocols is needed.
Keywords: Antinuclear antibodies (ANA); HEp-2 cells; ICAP; Indirect immunofluorescence (IIF); Survey.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Solomon DH, Kavanaugh AJ, Schur PH, Solomon DH, Schur P, Kavanaugh AF, Reveille JD, Sherrer YRS, Lahita R. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Care Res. 2002;47:434–44. https://doi.org/10.1002/art.10561 . - DOI
-
- Bossuyt X, De Langhe E, Borghi MO, Meroni PL. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases. Nat Rev Rheumatol. 2020;16:715–26. https://doi.org/10.1038/s41584-020-00522-w . - DOI - PubMed
-
- Damoiseaux J, von Mühlen CA, Garcia-De La Torre I, Carballo OG, de Melo Cruvinel W, Francescantonio PLC, Fritzler MJ, Herold M, Mimori T, Satoh M, et al. International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results Autoimmun. Highlights. 2016;7:1–8. https://doi.org/10.1007/s13317-016-0075-0 . - DOI
-
- Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71:1400–12. https://doi.org/10.1002/art.40930 . - DOI - PubMed - PMC
-
- Van Hoovels L, Broeders S, Chan EKL, Andrade L, de Melo Cruvinel W, Damoiseaux J, Viander M, Herold M, Coucke W, Heijnen I et al Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns: results of an international survey. Autoimmun Highlights. 2020;11. https://doi.org/10.1186/s13317-020-00139-9 .
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical